Oregon Public Employees Retirement Fund’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $403K | Buy |
12,798
+100
| +0.8% | +$3.15K | 0.01% | 1190 |
|
2025
Q1 | $416K | Sell |
12,698
-300
| -2% | -$9.83K | 0.01% | 1175 |
|
2024
Q4 | $470K | Hold |
12,998
| – | – | 0.01% | 1183 |
|
2024
Q3 | $405K | Sell |
12,998
-300
| -2% | -$9.35K | 0.01% | 1225 |
|
2024
Q2 | $356K | Sell |
13,298
-1,300
| -9% | -$34.8K | 0.01% | 1237 |
|
2024
Q1 | $498K | Sell |
14,598
-1,400
| -9% | -$47.8K | 0.01% | 1160 |
|
2023
Q4 | $463K | Sell |
15,998
-255
| -2% | -$7.38K | 0.01% | 1245 |
|
2023
Q3 | $448K | Sell |
16,253
-700
| -4% | -$19.3K | 0.01% | 1318 |
|
2023
Q2 | $510K | Sell |
16,953
-400
| -2% | -$12K | 0.01% | 1300 |
|
2023
Q1 | $629K | Sell |
17,353
-250
| -1% | -$9.06K | 0.01% | 1210 |
|
2022
Q4 | $628K | Sell |
17,603
-30
| -0.2% | -$1.07K | 0.01% | 1202 |
|
2022
Q3 | $597K | Buy |
17,633
+225
| +1% | +$7.62K | 0.01% | 1178 |
|
2022
Q2 | $503K | Sell |
17,408
-2,700
| -13% | -$78K | 0.01% | 1124 |
|
2022
Q1 | $650K | Sell |
20,108
-500
| -2% | -$16.2K | 0.01% | 1297 |
|
2021
Q4 | $601K | Sell |
20,608
-1,000
| -5% | -$29.2K | 0.01% | 1236 |
|
2021
Q3 | $576K | Sell |
21,608
-100
| -0.5% | -$2.67K | 0.01% | 1252 |
|
2021
Q2 | $668K | Hold |
21,708
| – | – | 0.01% | 1213 |
|
2021
Q1 | $568K | Buy |
21,708
+400
| +2% | +$10.5K | 0.01% | 1271 |
|
2020
Q4 | $536K | Sell |
21,308
-331
| -2% | -$8.33K | 0.01% | 1211 |
|
2020
Q3 | $451K | Buy |
21,639
+600
| +3% | +$12.5K | 0.01% | 1154 |
|
2020
Q2 | $500K | Hold |
21,039
| – | – | 0.01% | 1108 |
|
2020
Q1 | $378K | Hold |
21,039
| – | – | 0.01% | 1133 |
|
2019
Q4 | $499K | Hold |
21,039
| – | – | 0.01% | 1213 |
|
2019
Q3 | $578K | Buy |
21,039
+400
| +2% | +$11K | 0.01% | 1203 |
|
2019
Q2 | $683K | Buy |
20,639
+400
| +2% | +$13.2K | 0.01% | 1145 |
|
2019
Q1 | $709K | Buy |
20,239
+366
| +2% | +$12.8K | 0.01% | 1112 |
|
2018
Q4 | $660K | Buy |
+19,873
| New | +$660K | 0.01% | 1090 |
|